Selegiline
Back to searchMolecule Structure
Scientific Name
Selegiline
Description of the Drug
Selegiline is a monoamine oxidase inhibitor used to treat major depressive disorder and Parkinson’s.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01037
http://www.drugbank.ca/drugs/DB01037
Brand Name(s)
Eldepryl, Emsam, Zelapar
Company Owner(s)
Apotex Inc, Apotex Inc Etobicoke Site, G And W Laboratories Inc, Boscogen Inc, I3 Pharmaceuticals Llc, Rising Pharma Holdings Inc, Mylan Pharmaceuticals Inc, Lannett Co Inc, Chartwell Molecules Llc, Somerset Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Monoamine oxidase B | SINGLE PROTEIN | INHIBITOR | CHEMBL2039 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL22232 | ||||||
| PharmGKB | PA451316 | ||||||
| DrugBank | DB01037 | ||||||
| PubChem: Thomson Pharma | 14797266 | 14772861 | |||||
| PubChem | 26757 | ||||||
| LINCS | LSM-5920 | ||||||
| Nikkaji | J34.132K | ||||||
| BindingDB | 15579 | ||||||
| EPA CompTox Dashboard | DTXSID6023575 | ||||||
| DrugCentral | 2429 | ||||||
| Metabolights | MTBLC9086 | ||||||
| Brenda | 107161 | 10327 | 25451 | 174639 | 163217 | 4383 | 36352 |
| ChemicalBook | CB2137450 | ||||||
| Guide to Pharmacology | 6639 | ||||||
| rxnorm | EMSAM | ELDEPRYL | ZELAPAR | SELEGILINE | SELEGILINE HYDROCHLORIDE | ||
| KEGG Ligand | C07245 | ||||||
| ChEBI | 9086 | ||||||
| ZINC | ZINC000019632633 |
